Asthma Medications Market Growth Analysis up to 2027

Transparency Market Research (TMR) has published a new report on the asthma treatment market for the forecast period of 2019-2027. According to the report, the global asthma treatment market was valued at ~US$ 25 Bn in 2018, and is projected to expand at a CAGR of ~2% from 2019 to 2027.

Report Overview @ https://www.transparencymarketresearch.com/asthma-treatment-market.html

Overview

Asthma treatment involves two main types of medications: long-term asthma control medications and quick-relief (rescue) medications.

Asthma can usually be managed with rescue inhalers (salbutamol) to treat its symptoms and controller inhalers (steroids) that prevent its symptoms. However, severe asthma cases require long-acting inhalers that keep the airways open (formoterol, salmeterol, tiotropium), as well as inhalant steroids.
Growth of the global asthma treatment market can be attributed to the increase in the number of asthma patients across the globe.

North America dominated the global asthma treatment market in 2018, and the trend is anticipated to continue during the forecast period. Increase in the adoption of combination therapy, presence of major companies operating in the asthma treatment market in the region, and the introduction of new drugs such as combination therapy and increase in use of these drugs in the near future are factors that are likely to drive the asthma treatment market in North America.
Asia Pacific is expected to be a highly lucrative market for asthma treatment.

Request PDF Sample of Asthma Medications Market Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=73640

Increase in Prevalence of Asthma and Rise in Awareness to Drive Market

Increase in the prevalence of asthma across the global is a major factor fueling the growth of the global asthma treatment market. The disease is increasingly affecting adults as well as the pediatric population due to genetics or environmental factors, including microbial exposure, exposure to passive smoking, and air pollution, thereby propelling the need for asthma treatment.

According to the World Health Organization, currently, 235 million people around the world are suffering from asthma, and 338,000 deaths due to asthma were reported in 2015.

As per the Centers for Disease Control and Prevention (CDC) analysis data, asthma prevalence was 7.8% in 2015, which increased to 7.9% in 2017, in North America alone.

Asthma is one of the common lifelong chronic diseases. However, currently, people are increasingly becoming aware about asthma and its treatment, thus propelling the growth of the asthma treatment market.

World Asthma Day is an annual event organized by the Global Initiative for Asthma (GINA) to improve asthma awareness and care around the world. The month of May is considered as the National Asthma and Allergy Awareness Month, to educate people and raise awareness.

Buy Now "Asthma Medications Market" Research Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=73640<ype=S

Long-term Asthma Control Medications to Dominate Asthma Treatment Market

The long-term asthma control medications segment dominated the global asthma treatment market in 2018, and the trend is likely to continue during the forecast period, owing to continuous innovation in long-term therapy such as combination therapy, to provide comfort to patients and prevent symptoms.
Inhaled Route of Administration to be Promising

The inhaled segment dominated the global asthma treatment market in 2018. It is the most lucrative route of administration segment of the global asthma treatment market.

Growth of the inhaled segment can be attributed to inhaled drug therapy for asthma treatment. This is a preferred route of administration of medicine, as it is absorbed directly by the epithelium of the lungs.

Retail Pharmacies Accounted for Major Share of Asthma Treatment Market

The retail pharmacies segment dominated the global asthma treatment market, in terms of revenue, in 2018, and the trend is projected to continue during the forecast period. Increase in the number of asthma therapeutics being distributed through retail pharmacies and rise in the number of retail pharmacies in developing countries make these pharmacies a major channel of distribution.
North America to Dominate Global Asthma Treatment Market

North America accounted for a major share of the global asthma treatment market in 2018, owing to the introduction of new drugs, such as the availability of combination therapy and increase in the use of these drugs, and increase in the number of asthma cases in countries such as the U.S.

The asthma treatment market in Asia Pacific is likely to expand at a high CAGR from 2019 to 2027. Significant growth of the asthma treatment market in the region can be attributed to a rise in the prevalence of asthma and increase in the demand for asthma therapeutics.
Competitive Landscape

AstraZeneca plc., Boehringer Ingelheim International GmbH, GlaxoSmithKline plc are the leading players in the global asthma treatment market.

The global asthma treatment market is fragmented in terms of number of players. Key players in the global asthma treatment market include Mylan N.V., AstraZeneca plc., Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc., Merck & Co., Inc., Novartis AG, Sanofi, Sunovion Pharmaceuticals, Inc., and Teva Pharmaceutical Industries.

New product development through robust R&D activities and mergers & acquisitions are key strategies adopted by these players to expand in the global asthma treatment market.

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

This release was published on openPR.